{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T22:07:23Z","timestamp":1781129243385,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009104","name":"Universit\u00e0 degli Studi di Modena e Reggio Emilia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009104","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract\u00a0\u00a0\u00a0<\/jats:title>\n          <jats:p>The aims of this study were to investigate the prevalence of cryofibrinogenemia in a cohort of patients with systemic sclerosis (SSc) regardless of clinical manifestations, who were admitted to our hospital and determine the associations among CF positivity, disease features and ongoing therapies. This was a monocentric and retrospective study. The inclusion criteria were a diagnosis of SSc (according to the ACR\/EULAR 2013 classification criteria), regular administration of i.v. prostanoids, and CF testing between February 2020 and February 2022. Data on demographic, clinical, and immunological features and ongoing treatments were retrospectively collected. Categorical data were compared with the chi-square test or Fisher\u2019s exact test, while quantitative variables comparisons were carried out with Student\u2019s t test or Mann\u2012Whitney test. In total, 101 SSc patients were ultimately enrolled. The majority of patients were female (92.1%) and had the limited cutaneous form of SSc (81.2%). CF positivity was observed in 69.3% of the patients, whereas only 9% presented cryoglobulins and CF. CF positivity was negatively associated to RNAP3 antibodies (<jats:italic>p<\/jats:italic>\u2009=\u20090.027). No direct associations with specific clinical phenotypes were observed. No associations with immunosuppressive treatments were identified, however a positive association with nifedipine administration (<jats:italic>p<\/jats:italic>\u2009=\u20090.040), and a negative association with endothelin receptor antagonists (ERAs) plus phosphodiesterase-5 (PDE5) inhibitors regimen (<jats:italic>p<\/jats:italic>\u2009=\u20090.031) were observed. Macitentan administration was also associated to CF cryocrit\u2009\u2265\u20091% (<jats:italic>p<\/jats:italic>\u2009=\u20090.045). Among patients who were not treated with ERAs, an estimated pulmonary artery systolic pressure\u2009\u2265\u200930\u00a0mmHg was significantly associated with CF positivity (<jats:italic>p<\/jats:italic>\u2009=\u20090.025). Moreover, a cryocrit\u2009\u22653% was associated with a relative risk of 3.44 (95% CI 1.26\u20139.39, <jats:italic>p<\/jats:italic>\u2009=\u20090.016) for digital amputation and 5.17 (95% CI 1.18\u201322.6, <jats:italic>p<\/jats:italic>\u2009=\u20090.029) for death. Isolated CF is a frequent phenomenon observed in SSc patients and is associated with a higher administration of vasoactive drugs, probably identifying a SSc clinical phenotype with a more severe microvascular involvement. Moreover, a higher cryocrit is associated with an increased risk of death and digital amputations. Screening SSc patients for CF would represent an opportunity to provide better therapeutic approaches by anticipating ERA administration in an earlier phase, thereby preventing the manifestation of severe microvascular involvement.\n<jats:table-wrap>\n              <jats:table>\n                <jats:tbody>\n                  <jats:tr>\n                    <jats:td align=\"left\" colspan=\"2\">\n                      <jats:bold>Key Points<\/jats:bold>\u2022 <jats:italic>Cryofibrinogen is a cryoprotein that can cause microangiopathic damage.<\/jats:italic>\u2022 <jats:italic>Isolated cryofibrinogenemia is common in patients with systemic sclerosis.<\/jats:italic>\u2022 <jats:italic>SSc patients should be tested for cryofibrinogen because a high cryocrit (\u2265\u20093%) is associated with death and\/or digital amputation due to necrosis.<\/jats:italic>\u2022 <jats:italic>Cryofibrinogen is associated with indirect markers of pulmonary arterial hypertension in patients not treated with endothelin receptor agonists (ERAs).<\/jats:italic>\u2022 <jats:italic>ERAs could play a role in preventing cryofibrinogen damage.<\/jats:italic>\n                    <\/jats:td>\n                  <\/jats:tr>\n                <\/jats:tbody>\n              <\/jats:table>\n            <\/jats:table-wrap>\n          <\/jats:p>","DOI":"10.1007\/s10067-025-07324-z","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T07:18:23Z","timestamp":1737357503000},"page":"1173-1185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Secondary cryofibrinogenemia is related to more severe microangiopathic involvement in systemic sclerosis: results from a retrospective observational study"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0454-1093","authenticated-orcid":false,"given":"Gilda","family":"Sandri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1359-9580","authenticated-orcid":false,"given":"Gabriele","family":"Amati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4941-8507","authenticated-orcid":false,"given":"Amelia","family":"Spinella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8568-0866","authenticated-orcid":false,"given":"Patrizia","family":"Natali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2869-5126","authenticated-orcid":false,"given":"Daria","family":"Debbia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6784-2235","authenticated-orcid":false,"given":"Martina","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4954-9728","authenticated-orcid":false,"given":"Ottavio","family":"Secchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Bongiovanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0947-8663","authenticated-orcid":false,"given":"Marco","family":"de Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6010-3242","authenticated-orcid":false,"given":"Maria Teresa","family":"Mascia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0041-3695","authenticated-orcid":false,"given":"Dilia","family":"Giuggioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"7324_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1046\/j.1365-2249.2000.01210.x","volume":"120","author":"H Blain","year":"2000","unstructured":"Blain H, Cacoub P, Musset L et al (2000) Cryofibrinogenaemia: a study of 49 patients. Clin Exp Immunol 120:253\u2013260. https:\/\/doi.org\/10.1046\/j.1365-2249.2000.01210.x","journal-title":"Clin Exp Immunol"},{"key":"7324_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3899\/jrheum.110793","volume":"39","author":"MS Soyfoo","year":"2012","unstructured":"Soyfoo MS, Goubella A, Cogan E et al (2012) Clinical significance of Cryofibrinogenemia: possible pathophysiological link with Raynaud\u2019s phenomenon. J Rheumatol 39:119\u2013124. https:\/\/doi.org\/10.3899\/jrheum.110793","journal-title":"J Rheumatol"},{"key":"7324_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/rheumatology\/kem341","volume":"47","author":"CC Belizna","year":"2008","unstructured":"Belizna CC, Tron F, Joly P et al (2008) Outcome of essential cryofibrinogenaemia in a series of 61 patients. Rheumatology (Oxford) 47:205\u2013207. https:\/\/doi.org\/10.1093\/rheumatology\/kem341","journal-title":"Rheumatology (Oxford)"},{"key":"7324_CR4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.amjmed.2003.09.033","volume":"116","author":"TD Amdo","year":"2004","unstructured":"Amdo TD, Welker JA (2004) An approach to the diagnosis and treatment of cryofibrinogenemia. Am J Med 116:332\u2013337. https:\/\/doi.org\/10.1016\/j.amjmed.2003.09.033","journal-title":"Am J Med"},{"key":"7324_CR5","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.amjmed.2009.03.040","volume":"122","author":"D Saadoun","year":"2009","unstructured":"Saadoun D, Elalamy I, Ghillani-Dalbin P et al (2009) Cryofibrinogenemia: new insights into clinical and pathogenic features. Am J Med 122:1128\u20131135. https:\/\/doi.org\/10.1016\/j.amjmed.2009.03.040","journal-title":"Am J Med"},{"key":"7324_CR6","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/ajcp\/58.5.524","volume":"58","author":"SB Smith","year":"1972","unstructured":"Smith SB, Arkin C (1972) Cryofibrinogenemia: incidence, clinical correlations, and a review of the literature. Am J Clin Pathol 58:524\u2013530. https:\/\/doi.org\/10.1093\/ajcp\/58.5.524","journal-title":"Am J Clin Pathol"},{"key":"7324_CR7","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/rheumatology\/kew379","volume":"56","author":"S Moiseev","year":"2017","unstructured":"Moiseev S, Luqmani R, Novikov P, Shevtsova T (2017) Cryofibrinogenaemia-a neglected disease. Rheumatology (Oxford) 56:1445\u20131451. https:\/\/doi.org\/10.1093\/rheumatology\/kew379","journal-title":"Rheumatology (Oxford)"},{"key":"7324_CR8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/RHU.0b013e318289e06e","volume":"19","author":"M Michaud","year":"2013","unstructured":"Michaud M, Pourrat J (2013) Cryofibrinogenemia. J Clin Rheumatol 19:142\u2013148. https:\/\/doi.org\/10.1097\/RHU.0b013e318289e06e","journal-title":"J Clin Rheumatol"},{"key":"7324_CR9","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.amjmed.2008.03.011","volume":"121","author":"A Delluc","year":"2008","unstructured":"Delluc A, Saadoun D, Ghillani-Dalbin P et al (2008) Cryofibrinogen in patients with hepatitis C virus infection. Am J Med 121:624\u2013631. https:\/\/doi.org\/10.1016\/j.amjmed.2008.03.011","journal-title":"Am J Med"},{"key":"7324_CR10","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3748\/wjg.v12.i10.1621","volume":"12","author":"K Sawada","year":"2006","unstructured":"Sawada K, Takahashi R, Saniabadi AR et al (2006) Elevated plasma cryofibrinogen in patients with active inflammatory bowel disease is morbigenous. World J Gastroenterol 12:1621\u20131625. https:\/\/doi.org\/10.3748\/wjg.v12.i10.1621","journal-title":"World J Gastroenterol"},{"key":"7324_CR11","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1515\/cclm-2022-0423","volume":"60","author":"P Natali","year":"2022","unstructured":"Natali P, Debbia D, Cucinelli MR et al (2022) Analysis of cryoproteins with a focus on cryofibrinogen: a study on 103 patients. Clin Chem Lab Med 60:1796\u20131803. https:\/\/doi.org\/10.1515\/cclm-2022-0423","journal-title":"Clin Chem Lab Med"},{"key":"7324_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12016-010-8198-y","volume":"40","author":"E Hachulla","year":"2011","unstructured":"Hachulla E, Launay D (2011) Diagnosis and classification of systemic sclerosis. Clin Rev Allergy Immunol 40:78\u201383. https:\/\/doi.org\/10.1007\/s12016-010-8198-y","journal-title":"Clin Rev Allergy Immunol"},{"key":"7324_CR13","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390:1685\u20131699. https:\/\/doi.org\/10.1016\/S0140-6736(17)30933-9","journal-title":"Lancet"},{"key":"7324_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrrheum.2016.223","volume":"13","author":"J Varga","year":"2017","unstructured":"Varga J, Marangoni RG (2017) Systemic sclerosis in 2016: Dermal white adipose tissue implicated in SSc pathogenesis. Nat Rev Rheumatol 13:71\u201372. https:\/\/doi.org\/10.1038\/nrrheum.2016.223","journal-title":"Nat Rev Rheumatol"},{"key":"7324_CR15","doi-asserted-by":"publisher","first-page":"102727","DOI":"10.1016\/j.jaut.2021.102727","volume":"124","author":"C Ferri","year":"2021","unstructured":"Ferri C, Arcangeletti MC, Caselli E et al (2021) Insights into the knowledge of complex diseases: Environmental infectious\/toxic agents as potential etiopathogenetic factors of systemic sclerosis. J Autoimmun 124:102727. https:\/\/doi.org\/10.1016\/j.jaut.2021.102727","journal-title":"J Autoimmun"},{"issue":"3","key":"7324_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/25785826.2020.1754692","volume":"43","author":"M Jinnin","year":"2020","unstructured":"Jinnin M (2020) \u201cNarrow-sense\u201d and \u201cbroad-sense\u201d vascular abnormalities of systemic sclerosis. Immunol Med 43(3):107\u2013114. https:\/\/doi.org\/10.1080\/25785826.2020.1754692","journal-title":"Immunol Med"},{"key":"7324_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","volume":"81","author":"C Ferri","year":"2002","unstructured":"Ferri C, Valentini G, Cozzi F et al (2002) Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 81:139\u2013153. https:\/\/doi.org\/10.1097\/00005792-200203000-00004","journal-title":"Medicine (Baltimore)"},{"key":"7324_CR18","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1007\/s10238-023-01222-x","volume":"23","author":"F Marongiu","year":"2023","unstructured":"Marongiu F, Ruberto MF, Marongiu S et al (2023) A journey to vasculopathy in systemic sclerosis: focus on haemostasis and thrombosis. Clin Exp Med 23:4057\u20134064. https:\/\/doi.org\/10.1007\/s10238-023-01222-x","journal-title":"Clin Exp Med"},{"key":"7324_CR19","doi-asserted-by":"publisher","first-page":"103133","DOI":"10.1016\/j.autrev.2022.103133","volume":"21","author":"CS De Almeida","year":"2022","unstructured":"De Almeida CS, Puissant B, Porel T et al (2022) Clinical impact and prognosis of cryoglobulinemia and cryofibrinogenemia in systemic sclerosis. Autoimmun Rev 21:103133. https:\/\/doi.org\/10.1016\/j.autrev.2022.103133","journal-title":"Autoimmun Rev"},{"key":"7324_CR20","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 72:1747\u20131755. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204424","journal-title":"Ann Rheum Dis"},{"key":"7324_CR21","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","volume":"57","author":"JC Brouet","year":"1974","unstructured":"Brouet JC, Clauvel JP, Danon F et al (1974) Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 57:775\u2013788. https:\/\/doi.org\/10.1016\/0002-9343(74)90852-3","journal-title":"Am J Med"},{"key":"7324_CR22","volume-title":"Practical statistics for medical research","author":"DG Altman","year":"1991","unstructured":"Altman DG (1991) Practical statistics for medical research. Chapman and Hall, London"},{"key":"7324_CR23","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.autrev.2013.06.013","volume":"12","author":"D Giuggioli","year":"2013","unstructured":"Giuggioli D, Manfredi A, Colaci M et al (2013) Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. Autoimmun Rev 12:1058\u20131063. https:\/\/doi.org\/10.1016\/j.autrev.2013.06.013","journal-title":"Autoimmun Rev"},{"issue":"10","key":"7324_CR24","doi-asserted-by":"publisher","first-page":"e004580","DOI":"10.1136\/rmdopen-2024-004580","volume":"20","author":"K Didier","year":"2024","unstructured":"Didier K, Sobanski V, Robbins A et al (2024) Impact of autoantibody status on stratifying the risk of organ involvement and mortality in SSc: experience from a multicentre French cohort of 1605 patients. RMD Open 20(10):e004580. https:\/\/doi.org\/10.1136\/rmdopen-2024-004580","journal-title":"RMD Open"},{"key":"7324_CR25","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1093\/rheumatology\/key134","volume":"57","author":"A Kocoloski","year":"2018","unstructured":"Kocoloski A, Aggarwal R, Lienesch D (2018) Successful management of secondary cryofibrinogenaemia using bosentan therapy. Rheumatology (Oxford) 57:1868\u20131870. https:\/\/doi.org\/10.1093\/rheumatology\/key134","journal-title":"Rheumatology (Oxford)"},{"key":"7324_CR26","doi-asserted-by":"publisher","unstructured":"Del Galdo F, Lescoat A, Conaghan PG et al (2024) EULAR recommendations for the treatment of systemic sclerosis: 2023 update. Ann Rheum Dis 226430. https:\/\/doi.org\/10.1136\/ard-2024-226430","DOI":"10.1136\/ard-2024-226430"},{"key":"7324_CR27","doi-asserted-by":"publisher","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","volume":"61","author":"M Humbert","year":"2023","unstructured":"Humbert M, Kovacs G, Hoeper MM et al (2023) 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 61:2200879. https:\/\/doi.org\/10.1183\/13993003.00879-2022","journal-title":"Eur Respir J"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07324-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07324-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07324-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T08:19:28Z","timestamp":1740557968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07324-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["7324"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07324-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"15 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data sets generated during and\/or analyzed during the current study are available from the corresponding author upon reasonable request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Open data sharing"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}